What Does Spotlight Therapeutics Do?

Total employees75
HeadquartersAlameda
Founded2018

Spotlight Therapeutics is a pioneering biotechnology company focused on developing a new class of medicines using its proprietary TAGE™ (Targeted Active Gene Editors) platform. This platform is designed for cell-targeted in vivo CRISPR gene editing, aiming to deliver one-time, curative therapies for debilitating genetic diseases. The company's research spans several therapeutic areas, including immuno-oncology, ophthalmic diseases, hemoglobinopathies, and immunology, with the goal of directly correcting the root cause of genetic disorders within the patient's body.

Where Is Spotlight Therapeutics's Headquarters?

Spotlight Therapeutics officeSpotlight Therapeutics officeSpotlight Therapeutics officeSpotlight Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

Primary research and development (R&D) laboratories and corporate operations, including scientific discovery, preclinical development, and strategic management.

Notable Features:

State-of-the-art laboratory facilities specifically designed and equipped for advanced CRISPR gene editing research and development.

Work Culture:

An innovative, collaborative, and science-driven environment. The culture emphasizes scientific rigor, rapid advancement of therapeutic programs, and a strong commitment to addressing unmet patient needs through cutting-edge genetic medicine. Expect a dynamic, fast-paced startup atmosphere.

HQ Significance:

Strategically located in the San Francisco Bay Area, a leading global hub for biotechnology, providing access to a rich ecosystem of talent, research institutions, and potential collaborators. The headquarters serves as the central node for all company operations and innovation.

Values Reflected in HQ: The headquarters embodies the company's core values of innovation, scientific excellence, precision, and a patient-centric approach to developing transformative therapies.

Location:

Spotlight Therapeutics is primarily based in the United States, with its headquarters and core R&D operations located in Alameda, California. While its physical presence is concentrated in the US, its scientific collaborations, potential future clinical trials, and engagement with the global scientific and investment communities may extend internationally. The company's TAGE™ platform aims to develop therapies for genetic diseases with a global patient population.

Street Address:

2 West Point Avenue, Suite 110

City:

Alameda

State/Province:

CA

Country:

United States

Where Else Does Spotlight Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Spotlight Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Spotlight Therapeutics? Meet the Executive Team

As of April 2025, Spotlight Therapeutics' leadership includes:

Mary Haak-Frendscho, Ph.D. - President & Chief Executive Officer
Peter Cameron, Ph.D. - Chief Scientific Officer
Joanne Lager, M.D. - Chief Medical Officer
Cynthia Dolan, M.B.A. - Chief Financial Officer

Who's Investing in Spotlight Therapeutics?

Spotlight Therapeutics has been backed by several prominent investors over the years, including:

GV (Google Ventures)
MPM Capital
Casdin Capital
Rotating Boulder Fund
GordonMD Global Investments
EPIQ Capital Group
Medivate Partners

What Leadership Changes Has Spotlight Therapeutics Seen Recently?

Hire1
Exits0

Spotlight Therapeutics has been actively strengthening its executive leadership. A key appointment in scientific leadership (CSO) occurred in May 2023. Other significant C-suite additions (CMO, CFO) occurred in early 2023, slightly predating the strict 12-month window but contributing to the current robust executive team.

New Appointments:

Peter Cameron, Ph.D., Peter Cameron, Ph.D., joined Spotlight Therapeutics as Chief Scientific Officer, bringing extensive experience in drug discovery and development.

What Technology (Tech Stack) Is Used bySpotlight Therapeutics?

Discover the tools Spotlight Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Spotlight Therapeutics Email Formats and Examples

Spotlight Therapeutics likely utilizes common corporate email formats. While not publicly confirmed, patterns such as [first_initial][last]@[domain] or [first].[last]@[domain] are frequently used in the biotech industry.

[first_initial][last]@spotlighttx.com

Format

pcameron@spotlighttx.com

Example

80%

Success rate

What's the Latest News About Spotlight Therapeutics?

spotlighttx.comNovember 1, 2023

Spotlight Therapeutics News: Spotlight Therapeutics Presents Preclinical Data from its TAGE™ Platform at ESGCT 30th Annual Congress

Spotlight Therapeutics shared promising preclinical data on its TAGE™ (Targeted Active Gene Editors) platform at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress, highlighting advancements in its in vivo gene editing technology....more

spotlighttx.comMay 17, 2023

Spotlight Therapeutics News: Spotlight Therapeutics Presents New Preclinical Data from its TAGE™ Platform at ASGCT 26th Annual Meeting

The company presented new preclinical findings from its TAGE™ platform at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting, demonstrating progress in developing cell-targeted in vivo CRISPR gene editing therapies....more

spotlighttx.comMay 1, 2023

Spotlight Therapeutics News: Spotlight Therapeutics Appoints Peter Cameron, Ph.D., as Chief Scientific Officer

Spotlight Therapeutics announced the appointment of Peter Cameron, Ph.D., as its new Chief Scientific Officer to spearhead its research and development strategy....more

spotlighttx.comNovember 29, 2021

Spotlight Therapeutics News: Spotlight Therapeutics Completes $36.5 Million Series B Financing

Spotlight Therapeutics successfully closed a $36.5 million Series B financing round co-led by GordonMD Global Investments and EPIQ Capital Group, with participation from existing investors, to advance its TAGE platform and pipeline....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Spotlight Therapeutics, are just a search away.